US6096318A
(en)
|
1973-05-07 |
2000-08-01 |
The Ohio State University |
Antigenically modified HCG polypeptides
|
US4902506A
(en)
|
1983-07-05 |
1990-02-20 |
The University Of Rochester |
Immunogenic conjugates
|
GB8308235D0
(en)
*
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
US4816567A
(en)
*
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US5158769A
(en)
*
|
1984-03-07 |
1992-10-27 |
New York Blood Center, Inc. |
Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
|
US5417986A
(en)
|
1984-03-16 |
1995-05-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
US5208036A
(en)
*
|
1985-01-07 |
1993-05-04 |
Syntex (U.S.A.) Inc. |
N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
US4666829A
(en)
*
|
1985-05-15 |
1987-05-19 |
University Of California |
Polypeptide marker for Alzheimer's disease and its use for diagnosis
|
US5618920A
(en)
*
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
EP0247091B1
(en)
|
1985-11-01 |
1993-09-29 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
US4713366A
(en)
|
1985-12-04 |
1987-12-15 |
The Ohio State University Research Foundation |
Antigenic modification of polypeptides
|
US5096706A
(en)
*
|
1986-03-25 |
1992-03-17 |
National Research Development Corporation |
Antigen-based treatment for adiposity
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
US6548640B1
(en)
*
|
1986-03-27 |
2003-04-15 |
Btg International Limited |
Altered antibodies
|
JPS62267297A
(ja)
|
1986-05-15 |
1987-11-19 |
Tokyo Met Gov Seishin Igaku Sogo Kenkyusho |
老人斑反応性モノクロ−ナル抗体、それを産生する細胞株及び該モノクロ−ナル抗体の製造方法
|
US5278049A
(en)
*
|
1986-06-03 |
1994-01-11 |
Incyte Pharmaceuticals, Inc. |
Recombinant molecule encoding human protease nexin
|
US5231170A
(en)
|
1986-08-27 |
1993-07-27 |
Paul Averback |
Antibodies to dense microspheres
|
US5223482A
(en)
|
1986-11-17 |
1993-06-29 |
Scios Nova Inc. |
Recombinant Alzheimer's protease inhibitory amyloid protein and method of use
|
US5187153A
(en)
*
|
1986-11-17 |
1993-02-16 |
Scios Nova Inc. |
Methods of treatment using Alzheimer's amyloid polypeptide derivatives
|
US5220013A
(en)
|
1986-11-17 |
1993-06-15 |
Scios Nova Inc. |
DNA sequence useful for the detection of Alzheimer's disease
|
US4879213A
(en)
|
1986-12-05 |
1989-11-07 |
Scripps Clinic And Research Foundation |
Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
|
DE3702789A1
(de)
|
1987-01-30 |
1988-08-18 |
Bayer Ag |
Vorlaeuferprotein des apc-polypeptids, dafuer codierende dna und diagnostische verwendung der dna und des proteins
|
US4912206A
(en)
*
|
1987-02-26 |
1990-03-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
CDNA clone encoding brain amyloid of alzheimer's disease
|
DE3883899T3
(de)
|
1987-03-18 |
1999-04-22 |
Sb2 Inc |
Geänderte antikörper.
|
JPS63245689A
(ja)
|
1987-03-31 |
1988-10-12 |
Suntory Ltd |
ヒトアミロイド関連蛋白モノクロ−ナル抗体
|
US4883666A
(en)
|
1987-04-29 |
1989-11-28 |
Massachusetts Institute Of Technology |
Controlled drug delivery system for treatment of neural disorders
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
US5583112A
(en)
|
1987-05-29 |
1996-12-10 |
Cambridge Biotech Corporation |
Saponin-antigen conjugates and the use thereof
|
US5245015A
(en)
|
1991-04-26 |
1993-09-14 |
Tanox Biosystems, Inc. |
Monoclonal antibodies which neutralize HIV-1 through reaction with a conformational epitope in vitro
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
WO1988010120A1
(en)
|
1987-06-24 |
1988-12-29 |
Brigham And Women's Hospital |
Treatment of autoimmune diseases by oral administration of autoantigens
|
US5849298A
(en)
|
1987-06-24 |
1998-12-15 |
Autoimmune Inc. |
Treatment of multiple sclerosis by oral administration of bovine myelin
|
US5571500A
(en)
|
1987-06-24 |
1996-11-05 |
Autoimmune, Inc. |
Treatment of autoimmune diseases through administration by inhalation of autoantigens
|
US5645820A
(en)
|
1987-06-24 |
1997-07-08 |
Autoimmune, Inc. |
Treatment of autoimmune diseases by aerosol administration of autoantigens
|
US5869054A
(en)
*
|
1987-06-24 |
1999-02-09 |
Autoimmune Inc. |
Treatment of multiple sclerosis by oral administration of autoantigens
|
US5571499A
(en)
|
1987-06-24 |
1996-11-05 |
Autoimmune, Inc. |
Treatment of autoimmune diseases by aerosol administration of autoantigens
|
US5641474A
(en)
|
1987-06-24 |
1997-06-24 |
Autoimmune, Inc. |
Prevention of autoimmune diseases by aerosol administration of autoantigens
|
US5004697A
(en)
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
US4966753A
(en)
|
1987-08-18 |
1990-10-30 |
Molecular Rx, Inc. |
Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
|
US5677425A
(en)
|
1987-09-04 |
1997-10-14 |
Celltech Therapeutics Limited |
Recombinant antibody
|
CA1339014C
(en)
|
1987-10-08 |
1997-03-25 |
Ronald E. Majocha |
Antibodies to a4 amyloid peptide
|
US5231000A
(en)
|
1987-10-08 |
1993-07-27 |
The Mclean Hospital |
Antibodies to A4 amyloid peptide
|
AU2728588A
(en)
|
1987-10-23 |
1989-05-23 |
Genetics Institute Inc. |
Composition and method for treating cancers characterized by over-expression of the c-fms proto-oncogene
|
US5089603A
(en)
*
|
1989-06-21 |
1992-02-18 |
Tanox Biosystems, Inc. |
Antigenic epitopes present on membrane-bound but not secreted iga
|
WO1989006689A1
(en)
|
1988-01-13 |
1989-07-27 |
The Mclean Hospital Corporation |
Genetic constructs containing the alzheimer brain amyloid gene
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
US5576184A
(en)
|
1988-09-06 |
1996-11-19 |
Xoma Corporation |
Production of chimeric mouse-human antibodies with specificity to human tumor antigens
|
EP0442926A1
(en)
|
1988-11-10 |
1991-08-28 |
Imperial Cancer Research Technology Limited |
Polypeptides
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5227159A
(en)
|
1989-01-31 |
1993-07-13 |
Miller Richard A |
Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
|
US5262332A
(en)
|
1989-04-05 |
1993-11-16 |
Brigham And Women's Hospital |
Diagnostic method for Alzheimer's disease: examination of non-neural tissue
|
AU5439790A
(en)
|
1989-04-14 |
1990-11-16 |
Research Foundation For Mental Hygiene, Inc. |
Cerebrovascular amyloid protein-specific monoclonal antibody sv17-6e10
|
AU5525090A
(en)
|
1989-04-14 |
1990-11-16 |
Research Foundation For Mental Hygiene, Inc. |
Monoclonal antibody to amyloid peptide
|
CA2017507C
(en)
|
1989-05-25 |
1996-11-12 |
Gary Van Nest |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
DE69033487T2
(de)
|
1989-12-20 |
2000-06-29 |
Autoimmune Inc |
Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
|
US5859205A
(en)
*
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
CA2050918A1
(en)
|
1990-01-12 |
1991-07-13 |
Raju Kucherlapati |
Generation of xenogeneic antibodies
|
JPH05508621A
(ja)
|
1990-03-02 |
1993-12-02 |
オートイミューン インク |
自己抗原の経口投与による自己免疫疾患のダウンコントロール
|
EP0451700A1
(en)
|
1990-04-10 |
1991-10-16 |
Miles Inc. |
Recombinant APP minigenes for expression in transgenic mice as models for Alzheimers's disease
|
EP0527823A1
(en)
|
1990-04-24 |
1993-02-24 |
The Regents Of The University Of California |
Purification, detection and methods of use of protease nexin-2
|
US5753624A
(en)
|
1990-04-27 |
1998-05-19 |
Milkhaus Laboratory, Inc. |
Materials and methods for treatment of plaquing disease
|
GB9009548D0
(en)
|
1990-04-27 |
1990-06-20 |
Celltech Ltd |
Chimeric antibody and method
|
DE69126304T2
(de)
|
1990-04-27 |
1997-09-04 |
John Mcmichael |
Verfahren und zusammensetzung zur behandlung von erkrankungen des zns hervorgerufen durch abnormales beta-amyloid-protein
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
AU646877B2
(en)
*
|
1990-06-15 |
1994-03-10 |
Scios Nova Inc. |
Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease
|
CA2085897A1
(en)
|
1990-06-19 |
1991-12-20 |
George Pieczenik |
Nonpathogenic variant virus
|
GB9014932D0
(en)
|
1990-07-05 |
1990-08-22 |
Celltech Ltd |
Recombinant dna product and method
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US5780587A
(en)
|
1990-08-24 |
1998-07-14 |
President And Fellows Of Harvard College |
Compounds and methods for inhibiting β-protein filament formation and neurotoxicity
|
NZ239643A
(en)
|
1990-09-17 |
1996-05-28 |
North American Vaccine Inc |
Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
|
US5702906A
(en)
|
1990-09-25 |
1997-12-30 |
Genentech, Inc. |
Antibodies to neurotrophic factor-4 (NT-4)
|
CA2092823A1
(en)
|
1990-09-28 |
1992-03-29 |
Barry D. Greenberg |
Transgenic animals with alzheimer's amyloid precursor gene
|
EP0553244B8
(en)
|
1990-10-05 |
2005-06-08 |
Celldex Therapeutics, Inc. |
Targeted immunostimulation with bispecific reagents
|
AU9023791A
(en)
|
1990-10-15 |
1992-05-20 |
Brigham And Women's Hospital |
Treatment of autoimmune diseases by oral administration of autoantigens
|
GB9023352D0
(en)
|
1990-10-26 |
1990-12-05 |
Lynxvale Ltd |
Vaccinia vectors,vaccinia genes and expression products thereof
|
ES2335720T3
(es)
|
1991-01-21 |
2010-03-31 |
Elan Pharmaceuticals, Inc. |
Ensayo y modelo para la enfermedad de alzheimer.
|
WO1992015330A1
(fr)
|
1991-03-01 |
1992-09-17 |
Rhône Merieux |
Procede d'immunoneutralisation anti-lhrh des animaux domestiques males non castres et peptide pour cela
|
US5192753A
(en)
*
|
1991-04-23 |
1993-03-09 |
Mcgeer Patrick L |
Anti-rheumatoid arthritic drugs in the treatment of dementia
|
CA2086831C
(en)
|
1991-05-08 |
1999-03-16 |
Reinhard Gluck |
Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
|
WO1994004679A1
(en)
*
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
US5672805A
(en)
|
1991-07-18 |
1997-09-30 |
The Regents Of The University Of California |
Transgenic mice expressing the neurotoxic C-terminus of β-amyloid precursor protein
|
JP2966592B2
(ja)
|
1991-07-20 |
1999-10-25 |
萩原 義秀 |
安定化されたヒトモノクローナル抗体製剤
|
US5434050A
(en)
|
1991-08-13 |
1995-07-18 |
Regents Of The University Of Minnesota |
Labelled β-amyloid peptide and methods of screening for Alzheimer's disease
|
US5837268A
(en)
|
1991-10-16 |
1998-11-17 |
University Of Saskatchewan |
GnRH-leukotoxin chimeras
|
EP0746609A4
(en)
|
1991-12-17 |
1997-12-17 |
Genpharm Int |
NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES
|
CA2127450C
(en)
|
1992-01-07 |
2007-04-17 |
Samuel Wadsworth |
Transgenic animal models for alzheimer's disease
|
US5679348A
(en)
|
1992-02-03 |
1997-10-21 |
Cedars-Sinai Medical Center |
Immunotherapy for recurrent HSV infections
|
AU685047B2
(en)
|
1992-02-11 |
1998-01-15 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Dual carrier immunogenic construct
|
BR9306042A
(pt)
|
1992-02-28 |
1997-11-18 |
Autoimmune Inc |
Método para tratar uma doença auto-immune em um mamifero e formas de dosagens farmacêuticas oral e inalável
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
EP0561087B1
(en)
|
1992-03-20 |
1999-08-04 |
N.V. Innogenetics S.A. |
Mutated form of the beta-amyloid precursor protein gene
|
US5604102A
(en)
|
1992-04-15 |
1997-02-18 |
Athena Neurosciences, Inc. |
Methods of screening for β-amyloid peptide production inhibitors
|
US5441870A
(en)
*
|
1992-04-15 |
1995-08-15 |
Athena Neurosciences, Inc. |
Methods for monitoring cellular processing of β-amyloid precursor protein
|
US5851787A
(en)
*
|
1992-04-20 |
1998-12-22 |
The General Hospital Corporation |
Nucleic acid encoding amyloid precursor-like protein and uses thereof
|
EP0640094A1
(en)
|
1992-04-24 |
1995-03-01 |
The Board Of Regents, The University Of Texas System |
Recombinant production of immunoglobulin-like domains in prokaryotic cells
|
GB9209118D0
(en)
|
1992-04-28 |
1992-06-10 |
Sb 120 Amsterdam Bv |
Vaccine compositions
|
CA2138137C
(en)
*
|
1992-06-18 |
2004-11-09 |
R. John Collier |
Diphtheria toxin vaccines
|
ES2143716T3
(es)
|
1992-06-25 |
2000-05-16 |
Smithkline Beecham Biolog |
Composicion de vacuna que contiene adyuvantes.
|
US5766846A
(en)
|
1992-07-10 |
1998-06-16 |
Athena Neurosciences |
Methods of screening for compounds which inhibit soluble β-amyloid peptide production
|
US5837672A
(en)
|
1992-07-10 |
1998-11-17 |
Athena Neurosciences, Inc. |
Methods and compositions for the detection of soluble β-amyloid peptide
|
US6610493B1
(en)
|
1993-06-17 |
2003-08-26 |
Brigham And Women's Hospital |
Screening compounds for the ability to alter the production of amyloid-β peptide
|
WO1994001772A1
(en)
|
1992-07-13 |
1994-01-20 |
The Children's Medical Center Corporation |
SCREEN FOR ALZHEIMER'S DISEASE THERAPEUTICS BASED ON β-AMYLOID PRODUCTION
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
US6680182B1
(en)
|
1992-07-31 |
2004-01-20 |
Acambis Research Limited |
Expression of recombinant fusion proteins in attenuated bacteria
|
BR9306984A
(pt)
|
1992-08-27 |
1999-01-12 |
Deakin Res Ltd |
Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo
|
US5958883A
(en)
|
1992-09-23 |
1999-09-28 |
Board Of Regents Of The University Of Washington Office Of Technology |
Animal models of human amyloidoses
|
WO1994009364A1
(en)
|
1992-10-13 |
1994-04-28 |
Duke University |
Method of inhibiting binding of amyloid precursor protein to beta-amyloid protein
|
US5605811A
(en)
*
|
1992-10-26 |
1997-02-25 |
Athena Neurosciences, Inc. |
Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
|
PT1298436E
(pt)
|
1992-10-26 |
2010-10-21 |
Lilly Co Eli |
Métodos para a identificação de compostos inibidores da libertação de péptido beta-amilóide (bap)
|
US5972336A
(en)
|
1992-11-03 |
1999-10-26 |
Oravax Merieux Co. |
Urease-based vaccine against helicobacter infection
|
US6210671B1
(en)
*
|
1992-12-01 |
2001-04-03 |
Protein Design Labs, Inc. |
Humanized antibodies reactive with L-selectin
|
ATE237357T1
(de)
|
1993-01-22 |
2003-05-15 |
Sloan Kettering Inst Cancer |
Gangliosid-klh-konjugatimastoffe mit qs-21
|
US5955317A
(en)
|
1993-01-25 |
1999-09-21 |
Takeda Chemical Industries, Ltd. |
Antibodies to β-amyloids or their derivatives and use thereof
|
EP0683234B2
(en)
|
1993-01-25 |
2007-06-06 |
Takeda Chemical Industries, Ltd. |
Antibody against beta-amyloid or their derivative and use thereof
|
US5358708A
(en)
|
1993-01-29 |
1994-10-25 |
Schering Corporation |
Stabilization of protein formulations
|
US5472693A
(en)
|
1993-02-16 |
1995-12-05 |
The Dow Chemical Company |
Family of anti-carcinoembryonic antigen chimeric antibodies
|
DE614989T1
(de)
*
|
1993-02-17 |
1995-09-28 |
Morphosys Proteinoptimierung |
Verfahren für in vivo Selektion von Ligandenbindende Proteine.
|
CA2115900A1
(en)
|
1993-02-22 |
1994-08-23 |
Gerald W. Becker |
Pharmaceutical screens and antibodies
|
AU692152B2
(en)
*
|
1993-03-17 |
1998-06-04 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
|
DE69433870T2
(de)
|
1993-03-18 |
2005-06-30 |
Cytimmune Sciences, Inc. |
Zusammensetzung und methode zur reduktion der toxizität von biologisch-aktiven faktoren
|
EP0689454B2
(en)
|
1993-03-23 |
2005-02-23 |
SMITHKLINE BEECHAM BIOLOGICALS s.a. |
Vaccine compositions containing 3-o deacylated monophosphoryl lipid a
|
CA2119090A1
(en)
|
1993-03-26 |
1994-09-27 |
Wayne R. Gombotz |
Compositions for controlled release of biologically active tgf-.beta.
|
IT1270939B
(it)
|
1993-05-11 |
1997-05-26 |
Angeletti P Ist Richerche Bio |
Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili.
|
ES2150493T5
(es)
*
|
1993-05-25 |
2004-07-01 |
Wyeth Holdings Corporation |
Adyuvantes para vacunas contra el virus sincitico respiratorio.
|
AU7043894A
(en)
|
1993-05-28 |
1994-12-20 |
Miriam Hospital, The |
Composition and method for (in vivo) imaging of amyloid deposits
|
ES2171454T3
(es)
|
1993-06-04 |
2002-09-16 |
Whitehead Biomedical Inst |
Proteinas de estres y sus usos.
|
US5464823A
(en)
|
1993-07-20 |
1995-11-07 |
The Regents Of The University Of California |
Mammalian antibiotic peptides
|
JPH09500540A
(ja)
|
1993-07-30 |
1997-01-21 |
メデヴァ ホールディングス ビー.ヴイ. |
ワクチン組成物
|
JPH08503490A
(ja)
|
1993-08-18 |
1996-04-16 |
モルフォシス・ゲゼルシャフト・フュア・プロタインオプティミールング・ミット・ベシュレンクテル・ハフツング |
リポ多糖結合性および中和能のあるペプチド
|
WO1995005853A1
(en)
|
1993-08-26 |
1995-03-02 |
The Regents Of The University Of California |
Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
|
AU707083B2
(en)
|
1993-08-26 |
1999-07-01 |
Bavarian Nordic Inc. |
Inducing antibody response against self-proteins with the aid of foreign T-cell epitopes
|
DK96493D0
(da)
|
1993-08-26 |
1993-08-26 |
Mouritsen Og Elsner Aps |
Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
|
WO1995006407A1
(en)
|
1993-08-30 |
1995-03-09 |
The Regents Of The University Of California |
Novel component of amyloid in alzheimer's disease and methods for use of same
|
ES2236693T3
(es)
|
1993-09-07 |
2005-07-16 |
Smithkline Beecham Corporation |
Anticuerpos recombinantes contra il4 utiles en el tratamiento de afecciones mediadas por il4.
|
US5652334A
(en)
|
1993-09-08 |
1997-07-29 |
City Of Hope |
Method for design of substances that enhance memory and improve the quality of life
|
US5385887A
(en)
*
|
1993-09-10 |
1995-01-31 |
Genetics Institute, Inc. |
Formulations for delivery of osteogenic proteins
|
ES2318848T3
(es)
*
|
1993-09-14 |
2009-05-01 |
Pharmexa Inc. |
Peptidos que se unen a pan dr para potenciar la respuesta inmunitaria.
|
US5470951A
(en)
|
1993-09-29 |
1995-11-28 |
City Of Hope |
Peptides for antagonizing the effects of amyloid βprotein
|
US5858981A
(en)
*
|
1993-09-30 |
1999-01-12 |
University Of Pennsylvania |
Method of inhibiting phagocytosis
|
WO1995011311A1
(en)
|
1993-10-20 |
1995-04-27 |
Duke University |
METHOD OF BINDING MATERIAL TO THE β-AMYLOID PEPTIDE
|
CA2172507C
(en)
|
1993-10-22 |
2008-12-02 |
Jeffrey L. Cleland |
Methods and compositions for microencapsulation of antigens for use as vaccines
|
JP3504963B2
(ja)
|
1993-10-22 |
2004-03-08 |
智靖 羅 |
抗ヒト高親和性IgE受容体モノクローナル抗体に係るアミノ酸配列をコードするDNA断片
|
US5744368A
(en)
*
|
1993-11-04 |
1998-04-28 |
Research Foundation Of State University Of New York |
Methods for the detection of soluble amyloid β-protein (βAP) or soluble transthyretin (TTR)
|
JPH07132033A
(ja)
|
1993-11-12 |
1995-05-23 |
Hoechst Japan Ltd |
アルツハイマー病モデルトランスジェニック動物
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
US5434170A
(en)
|
1993-12-23 |
1995-07-18 |
Andrulis Pharmaceuticals Corp. |
Method for treating neurocognitive disorders
|
US5877399A
(en)
*
|
1994-01-27 |
1999-03-02 |
Johns Hopkins University |
Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
|
JPH09511388A
(ja)
|
1994-01-27 |
1997-11-18 |
リージェンツ オブ ザ ユニバーシティー オブ ミネソタ |
進行性神経疾患を持つヒト以外のトランスジェニック哺乳類
|
EP0802797A1
(en)
|
1994-02-03 |
1997-10-29 |
The Picower Institute For Medical Research |
Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
|
AUPM411994A0
(en)
|
1994-02-25 |
1994-03-24 |
Deakin Research Limited |
Epitopes
|
US5795954A
(en)
|
1994-03-04 |
1998-08-18 |
Genentech, Inc. |
Factor VIIa inhibitors from Kunitz domain proteins
|
US6270757B1
(en)
|
1994-04-21 |
2001-08-07 |
Genetics Institute, Inc. |
Formulations for IL-11
|
US6372716B1
(en)
|
1994-04-26 |
2002-04-16 |
Genetics Institute, Inc. |
Formulations for factor IX
|
CA2191101C
(en)
|
1994-05-25 |
2001-08-07 |
Ellis L. Kline |
Materials and methods for treatment of plaquing diseases
|
US5622701A
(en)
*
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
US5798100A
(en)
|
1994-07-06 |
1998-08-25 |
Immunomedics, Inc. |
Multi-stage cascade boosting vaccine
|
US6417178B1
(en)
|
1994-07-19 |
2002-07-09 |
University Of Pittsburgh |
Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits
|
NZ290089A
(en)
|
1994-07-27 |
1999-05-28 |
Queensland Inst Med Res |
Recombinant polyepitope cytotoxic t lymphocyte (ctl) vaccines
|
DE4432382A1
(de)
|
1994-09-12 |
1996-03-14 |
Schaeffler Waelzlager Kg |
Übertragungselement für eine Getriebeschaltung
|
US5872005A
(en)
|
1994-11-03 |
1999-02-16 |
Cell Genesys Inc. |
Packaging cell lines for adeno-associated viral vectors
|
US6114133A
(en)
|
1994-11-14 |
2000-09-05 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)
|
US5589154A
(en)
|
1994-11-22 |
1996-12-31 |
Rutgers, The State University Of New Jersey |
Methods for the prevention or treatment of vascular hemorrhaging and Alzheimer's disease
|
US5688651A
(en)
|
1994-12-16 |
1997-11-18 |
Ramot University Authority For Applied Research And Development Ltd. |
Prevention of protein aggregation
|
US5612030A
(en)
|
1995-01-17 |
1997-03-18 |
University Of Kentucky Research Foundation |
Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
|
AU695129B2
(en)
*
|
1995-02-06 |
1998-08-06 |
Genetics Institute, Llc |
Formulations for IL-12
|
US5786180A
(en)
|
1995-02-14 |
1998-07-28 |
Bayer Corporation |
Monoclonal antibody 369.2B specific for β A4 peptide
|
US5624937A
(en)
*
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
US5854215A
(en)
|
1995-03-14 |
1998-12-29 |
Praecis Pharmaceuticals Incorporated |
Modulators of β-amyloid peptide aggregation
|
US5817626A
(en)
|
1995-03-14 |
1998-10-06 |
Praecis Pharmaceuticals Incorporated |
Modulators of beta-amyloid peptide aggregation
|
WO1996028471A1
(en)
|
1995-03-14 |
1996-09-19 |
Praecis Pharmaceuticals Incorporated |
Modulators of amyloid aggregation
|
US6303567B1
(en)
|
1995-03-14 |
2001-10-16 |
Praecis Pharmaceuticals, Inc . |
Modulators of β-amyloid peptide aggregation comprising D-amino acids
|
EP0871755A1
(en)
|
1995-03-23 |
1998-10-21 |
Cantab Pharmaceuticals Research Limited |
Vectors for gene delivery
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
US5869046A
(en)
*
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
ATE274064T1
(de)
|
1995-05-23 |
2004-09-15 |
Morphosys Ag |
Multimere proteine
|
WO1996039176A1
(en)
|
1995-06-05 |
1996-12-12 |
Brigham & Women's Hospital |
USE OF ORAL TOLERANCE TO SUPPRESS BOTH Th1 AND Th2 IMMUNE RESPONSES AND TO SUPPRESS ANTIBODY PRODUCTION
|
US5948763A
(en)
|
1995-06-07 |
1999-09-07 |
New York University |
Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
|
AU6264996A
(en)
|
1995-06-07 |
1996-12-30 |
Athena Neurosciences, Inc. |
Method for identifying alzheimer's disease therapeutics usin g transgenic animal models
|
US5910427A
(en)
|
1995-06-22 |
1999-06-08 |
La Jolla Institute For Allergy And Immunology |
Antigen non-specific glycosylation inhibiting factor derivatives
|
PT750907E
(pt)
|
1995-06-30 |
2002-08-30 |
American Cyanamid Co |
Formulacoes de vacinas estaveis para administracao parenterica metodo para a sua utilizacao e processo para a sua preparacao
|
EP1637600A1
(en)
|
1995-07-07 |
2006-03-22 |
Darwin Molecular Corporation |
Chromosome 1 gene and gene products related to Alzheimer's disease
|
AUPN443995A0
(en)
|
1995-07-27 |
1995-08-17 |
Csl Limited |
Papillomavirus polyprotein
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
DE69621940T2
(de)
|
1995-08-18 |
2003-01-16 |
Morphosys Ag |
Protein-/(poly)peptidbibliotheken
|
US5824322A
(en)
|
1995-08-21 |
1998-10-20 |
Cytrx Corporation |
Compositions and methods for growth promotion
|
BR9610580A
(pt)
|
1995-09-14 |
2000-10-24 |
Univ California |
Anticorpos especìficos para prpse nativos
|
US5731284A
(en)
*
|
1995-09-28 |
1998-03-24 |
Amgen Inc. |
Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
|
AU3804995A
(en)
|
1995-10-10 |
1997-04-30 |
Novartis Ag |
Melanoma-associated protein
|
US5985242A
(en)
|
1995-10-27 |
1999-11-16 |
Praecis Pharmaceuticals, Inc. |
Modulators of β-amyloid peptide aggregation comprising D-amino acids
|
US5750361A
(en)
*
|
1995-11-02 |
1998-05-12 |
The Regents Of The University Of California |
Formation and use of prion protein (PRP) complexes
|
ES2203722T3
(es)
|
1995-11-10 |
2004-04-16 |
Elan Corporation, Plc |
Peptidos que faccilitan el transporte a traves de tejidos y metodos de identificarlos y usarlos.
|
WO1997018855A1
(en)
|
1995-11-21 |
1997-05-29 |
Eduard Naumovich Lerner |
Device for enhanced delivery of biologically active substances and compounds in an organism
|
WO1997021728A1
(en)
|
1995-12-12 |
1997-06-19 |
Karolinska Innovations Ab |
PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b)
|
JPH09178743A
(ja)
|
1995-12-27 |
1997-07-11 |
Oriental Yeast Co Ltd |
可溶性appの定量法
|
US6015662A
(en)
*
|
1996-01-23 |
2000-01-18 |
Abbott Laboratories |
Reagents for use as calibrators and controls
|
ZA97452B
(en)
|
1996-01-25 |
1997-08-15 |
Trinity College Dublin |
Streptococcus equi vaccine.
|
US5770700A
(en)
|
1996-01-25 |
1998-06-23 |
Genetics Institute, Inc. |
Liquid factor IX formulations
|
AU1832797A
(en)
|
1996-01-26 |
1997-08-20 |
Trustees Of Columbia University In The City Of New York, The |
A polypeptide from lung extract which binds amyloid-beta peptide
|
JPH09208485A
(ja)
|
1996-01-31 |
1997-08-12 |
Teijin Ltd |
ペプチド・蛋白質性薬物の水難溶性組成物
|
US6096313A
(en)
|
1996-02-09 |
2000-08-01 |
Ludwig Institute For Cancer Research |
Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
|
WO1997032017A1
(en)
|
1996-02-26 |
1997-09-04 |
Morphosys Gesellschaft Für Proteinoptimierung Mbh |
Novel method for the identification of nucleic acid sequences encoding two or more interacting (poly)peptides
|
US6150091A
(en)
|
1996-03-06 |
2000-11-21 |
Baylor College Of Medicine |
Direct molecular diagnosis of Friedreich ataxia
|
JP4229341B2
(ja)
|
1996-03-23 |
2009-02-25 |
財団法人阪大微生物病研究会 |
破傷風毒素の機能的フラグメント抗原及び破傷風ワクチン
|
JP2000507449A
(ja)
|
1996-03-29 |
2000-06-20 |
ユニバーシティ オブ オタゴ |
パラポックスウイルスベクター
|
AU713067B2
(en)
|
1996-04-03 |
1999-11-25 |
Anergen, Inc. |
Cyclic peptide vaccines for treatment and prevention of diabetes
|
JP2002506419A
(ja)
|
1996-04-19 |
2002-02-26 |
アメリカ合衆国 |
A型肝炎ウイルスポリタンパク質の抗原反応性領域
|
US6284533B1
(en)
|
1996-05-01 |
2001-09-04 |
Avant Immunotherapeutics, Inc. |
Plasmid-based vaccine for treating atherosclerosis
|
EP0938506B1
(en)
|
1996-07-16 |
2003-11-05 |
Plückthun, Andreas, Prof. Dr. |
Immunoglobulin superfamily domains and fragments with increased solubility
|
JP2000516090A
(ja)
|
1996-07-26 |
2000-12-05 |
スローン―ケッタリング インスティチュート フォー キャンサー リサーチ |
遺伝子的免疫化のための方法と試薬
|
US7147851B1
(en)
|
1996-08-15 |
2006-12-12 |
Millennium Pharmaceuticals, Inc. |
Humanized immunoglobulin reactive with α4β7 integrin
|
CA2183901A1
(en)
|
1996-08-22 |
1998-02-23 |
Johanna E. Bergmann |
Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans
|
GB9617616D0
(en)
|
1996-08-22 |
1996-10-02 |
Osteometer Biotech As |
Assaying protein fragments in body fluids
|
DK0929574T3
(da)
|
1996-08-27 |
2005-10-31 |
Praecis Pharm Inc |
Modulatorer af beta-amyloidpeptidaggregering, som omfatter D-aminosyrer
|
US6057367A
(en)
*
|
1996-08-30 |
2000-05-02 |
Duke University |
Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
|
US6797495B2
(en)
|
1996-11-05 |
2004-09-28 |
The Regents Of The University Of California |
Somatic cells with ablated PrP gene and methods of use
|
US6022859A
(en)
*
|
1996-11-15 |
2000-02-08 |
Wisconsin Alumni Research Foundation |
Inhibitors of β-amyloid toxicity
|
WO1998022120A1
(en)
|
1996-11-19 |
1998-05-28 |
The Wistar Institute Of Anatomy & Biology |
Diagnostic and therapeutic reagents for alzheimer's disease
|
US6962984B2
(en)
|
1996-12-05 |
2005-11-08 |
Nihon University |
IgA nephropathy-related DNA
|
US6218506B1
(en)
*
|
1997-02-05 |
2001-04-17 |
Northwestern University |
Amyloid β protein (globular assembly and uses thereof)
|
US20030068316A1
(en)
|
1997-02-05 |
2003-04-10 |
Klein William L. |
Anti-ADDL antibodies and uses thereof
|
WO1998039303A1
(en)
|
1997-03-03 |
1998-09-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
US5798102A
(en)
|
1997-03-04 |
1998-08-25 |
Milkhaus Laboratory, Inc. |
Treatment of cardiomyopathy
|
US6057098A
(en)
*
|
1997-04-04 |
2000-05-02 |
Biosite Diagnostics, Inc. |
Polyvalent display libraries
|
WO1998044955A1
(en)
|
1997-04-09 |
1998-10-15 |
Mindset Ltd. |
Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
|
US20020086847A1
(en)
|
1997-04-09 |
2002-07-04 |
Mindset Biopharmaceuticals (Usa) |
Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
|
US8173127B2
(en)
*
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
PL194221B1
(pl)
|
1997-04-15 |
2007-05-31 |
Pharmexa As |
Zmodyfikowana cząsteczka ludzkiego TNFalfa, dimery, oligomery lub multimery zmodyfikowanej cząsteczki ludzkiego TNFalfa, wyizolowana cząsteczka DNA, wektor, wektor ekspresyjny, komórka gospodarza, sposób wytwarzania zmodyfikowanej cząsteczki ludzkiego TNFalfa, szczepionki przeciwko TNFalfa oraz zastosowanie przynajmniej jednej zmodyfikowanej cząsteczki ludzkiego TNFalfa
|
US6787319B2
(en)
*
|
1997-04-16 |
2004-09-07 |
American Home Products Corp. |
β-amyloid peptide-binding proteins and polynucleotides encoding the same
|
AU7690898A
(en)
*
|
1997-05-20 |
1998-12-11 |
Ottawa Civic Hospital Loeb Research Institute |
Vectors and methods for immunization or therapeutic protocols
|
EP0999853B1
(en)
|
1997-06-13 |
2003-01-02 |
Genentech, Inc. |
Stabilized antibody formulation
|
AU8269898A
(en)
|
1997-06-27 |
1999-01-19 |
Regents Of The University Of California, The |
Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor
|
IT1293511B1
(it)
|
1997-07-30 |
1999-03-01 |
Gentili Ist Spa |
Anticorpi monoclonali catalitici ad attivita' proteasica per la lisi selettiva della componente proteica di placche e aggregati correlati
|
WO1999006587A2
(en)
|
1997-08-01 |
1999-02-11 |
Morphosys Ag |
Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex
|
WO1999006545A2
(en)
|
1997-08-01 |
1999-02-11 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
|
DE69840962D1
(de)
|
1997-08-29 |
2009-08-20 |
Antigenics Inc |
Adjuvant qs-21 enthaltende zusammensetzungen mit polysorbate oder cyclodextrin als hilfsmittel
|
US6175057B1
(en)
*
|
1997-10-08 |
2001-01-16 |
The Regents Of The University Of California |
Transgenic mouse model of alzheimer's disease and cerebral amyloid angiopathy
|
EP0921189B1
(en)
|
1997-11-14 |
2005-01-12 |
Sankyo Company Limited |
Transgenic animal allergy models and methods for their use
|
US6913745B1
(en)
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
US6787523B1
(en)
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
US6923964B1
(en)
|
1997-12-02 |
2005-08-02 |
Neuralab Limited |
Active immunization of AScr for prion disorders
|
US20080050367A1
(en)
*
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
US6743427B1
(en)
|
1997-12-02 |
2004-06-01 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
TWI239847B
(en)
*
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US6710226B1
(en)
*
|
1997-12-02 |
2004-03-23 |
Neuralab Limited |
Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics
|
US6750324B1
(en)
|
1997-12-02 |
2004-06-15 |
Neuralab Limited |
Humanized and chimeric N-terminal amyloid beta-antibodies
|
US7790856B2
(en)
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
US7179892B2
(en)
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
HUP0004821A2
(hu)
|
1997-12-03 |
2001-06-28 |
Fujisawa Pharmaceutical Co., Ltd. |
Lágy pellet alakjában lévő gyógyszerkészítmény és előállítása
|
JP2002511385A
(ja)
|
1997-12-03 |
2002-04-16 |
ニューララブ リミテッド |
アルツハイマー病におけるβ−アミロイド関連変化を抑制する方法
|
FR2777015B3
(fr)
|
1998-02-23 |
2000-09-15 |
Financ De Biotechnologie |
Procede et moyens pour l'obtention de modeles cellulaires et animaux de maladies neurodegeneratives
|
US6528624B1
(en)
*
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
US6194551B1
(en)
*
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
US20050059591A1
(en)
*
|
1998-04-07 |
2005-03-17 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
US20050059802A1
(en)
*
|
1998-04-07 |
2005-03-17 |
Neuralab Ltd |
Prevention and treatment of amyloidogenic disease
|
JP2002512776A
(ja)
|
1998-04-28 |
2002-05-08 |
スミスクライン・ビーチャム・コーポレイション |
免疫原性の低下したモノクローナル抗体
|
NO314086B1
(no)
|
1998-05-08 |
2003-01-27 |
Gemvax As |
Peptider og farmasöytiske sammensetninger inneholdende disse, nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slike DNA-sekvenser samt anvendelse av disse for fremstilling avfarmasöytiske preparater til
|
EP1080110A2
(en)
|
1998-05-19 |
2001-03-07 |
Yeda Research And Development Co. Ltd. |
Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system
|
US20030147882A1
(en)
|
1998-05-21 |
2003-08-07 |
Alan Solomon |
Methods for amyloid removal using anti-amyloid antibodies
|
DE69942274D1
(de)
|
1998-05-21 |
2010-06-02 |
Univ Tennessee Res Foundation |
Methoden zur amyloidentfernung mit anti-amyloid-antikörper
|
US6432710B1
(en)
|
1998-05-22 |
2002-08-13 |
Isolagen Technologies, Inc. |
Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
|
US6727349B1
(en)
*
|
1998-07-23 |
2004-04-27 |
Millennium Pharmaceuticals, Inc. |
Recombinant anti-CCR2 antibodies and methods of use therefor
|
EA003634B1
(ru)
|
1998-10-05 |
2003-08-28 |
Фармэкса А/С |
Новые способы терапевтической вакцинации
|
CA2354862A1
(en)
|
1998-10-19 |
2000-04-27 |
Yeda Research And Development Co. Ltd. |
Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
|
US7112661B1
(en)
|
1998-10-30 |
2006-09-26 |
The Research Foundation Of State University Of New York |
Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein Ib alpha
|
GB2348203B
(en)
|
1998-11-04 |
2002-06-19 |
Imp College Innovations Ltd |
Solube beta-forms of prion proteins, methods of preparation and use
|
ES2216509T3
(es)
|
1999-01-19 |
2004-10-16 |
PHARMACIA & UPJOHN COMPANY |
Procedimiento de envasado para sustancias medicinales sensibles a la oxidacion.
|
EP1146898A1
(en)
|
1999-01-22 |
2001-10-24 |
Matthew John During |
Vaccine-mediated treatment of neurological disorders
|
US7629311B2
(en)
|
1999-02-24 |
2009-12-08 |
Edward Lewis Tobinick |
Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
|
US7282570B2
(en)
*
|
1999-04-20 |
2007-10-16 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
ATE384077T1
(de)
|
1999-05-05 |
2008-02-15 |
Neurochem Int Ltd |
Stereoselektive antifibrillogene peptide
|
US6787637B1
(en)
|
1999-05-28 |
2004-09-07 |
Neuralab Limited |
N-Terminal amyloid-β antibodies
|
PE20010212A1
(es)
|
1999-06-01 |
2001-02-22 |
Neuralab Ltd |
Composiciones del peptido a-beta y procesos para producir las mismas
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
US6582945B1
(en)
|
1999-06-16 |
2003-06-24 |
Boston Biomedical Research Institute |
Immunological control of β-amyloid levels in vivo
|
DE19927554C2
(de)
*
|
1999-06-16 |
2002-12-19 |
Inst Mikrotechnik Mainz Gmbh |
Mikromischer
|
JP2003503083A
(ja)
|
1999-07-01 |
2003-01-28 |
サイオス,インコーポレーテッド |
アミロイド関連疾患の予防及び治療
|
WO2001005355A2
(en)
|
1999-07-15 |
2001-01-25 |
Genetics Institute, Inc. |
Formulations for il-11
|
ATE445639T1
(de)
|
1999-08-04 |
2009-10-15 |
Univ Southern California |
Globularer aufbau vom amyloid-beta- protein und deren verwendungen
|
IL142948A0
(en)
|
1999-09-03 |
2002-04-21 |
Univ Ramot |
Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases
|
US6294171B2
(en)
|
1999-09-14 |
2001-09-25 |
Milkhaus Laboratory, Inc. |
Methods for treating disease states comprising administration of low levels of antibodies
|
US6824780B1
(en)
|
1999-10-29 |
2004-11-30 |
Genentech, Inc. |
Anti-tumor antibody compositions and methods of use
|
AU784312B2
(en)
|
1999-11-29 |
2006-03-09 |
Bellus Health (International) Limited |
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
|
US20020094335A1
(en)
|
1999-11-29 |
2002-07-18 |
Robert Chalifour |
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
|
IL149976A0
(en)
|
1999-12-08 |
2002-12-01 |
Mindset Biopharmaceuticals Usa |
Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
|
US6399314B1
(en)
|
1999-12-29 |
2002-06-04 |
American Cyanamid Company |
Methods of detection of amyloidogenic proteins
|
CA2400838C
(en)
|
2000-02-21 |
2013-04-23 |
Pharmexa A/S |
Novel method for down-regulation of amyloid
|
EP1259251B1
(en)
|
2000-02-21 |
2005-10-19 |
Pharmexa A/S |
Novel method for down-regulation of amyloid
|
CZ306683B6
(cs)
*
|
2000-02-24 |
2017-05-03 |
Washington University |
Léčivo pro prevenci nebo léčení preklinické nebo klinické Alzheimerovy nemoci
|
US7485616B2
(en)
|
2000-04-05 |
2009-02-03 |
University Of Tennessee Research Foundation |
Methods of investigating, diagnosing, and treating amyloidosis
|
AU5162201A
(en)
|
2000-04-13 |
2001-10-30 |
Corixa Corporation |
Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and qs-21
|
DE60108111T2
(de)
*
|
2000-05-22 |
2005-12-08 |
New York University |
Synthetische immunogene jedoch nicht amyloidogene peptide, die homolog zu amyloid beta sind und deren verwendung zur induktion einer immunantwort gegen amyloid beta und amyloidaggregate
|
JP5362164B2
(ja)
|
2000-07-07 |
2013-12-11 |
バイオアークティック ニューロサイエンス アーベー |
アルツハイマー病の予防及び治療
|
US20020009445A1
(en)
*
|
2000-07-12 |
2002-01-24 |
Yansheng Du |
Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
|
EP1172378A1
(en)
|
2000-07-12 |
2002-01-16 |
Richard Dr. Dodel |
Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
|
US20030092145A1
(en)
*
|
2000-08-24 |
2003-05-15 |
Vic Jira |
Viral vaccine composition, process, and methods of use
|
DK1317479T3
(da)
|
2000-09-06 |
2009-11-23 |
Aventis Pharma Sa |
Fremgangsmåder og sammensætninger for sygdomme, der er associeret med amyloidosis
|
IT1319277B1
(it)
|
2000-10-24 |
2003-09-26 |
Chiesi Farma Spa |
Proteine di fusione utili per il trattamento di immunizzazione dellamalattia di alzheimer.
|
IL139308A0
(en)
|
2000-10-26 |
2001-11-25 |
Marikovsky Moshe |
Peptides from amyloid precursor protein which inhibit tumor growth and metastasis
|
WO2002064084A2
(en)
*
|
2000-11-02 |
2002-08-22 |
Cornell Research Foundation, Inc. |
In vivo multiphoton diagnostic detection and imaging of a neurodegenerative disease
|
PT1346041E
(pt)
|
2000-11-27 |
2007-06-05 |
Praecis Pharm Inc |
Agentes terapêuticos e métodos para a sua utilização no tratamento de uma doença amiloidogénica.
|
PE20020574A1
(es)
*
|
2000-12-06 |
2002-07-02 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido amiloideo beta
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
WO2002060920A2
(en)
|
2000-12-27 |
2002-08-08 |
Board Of Regents, University Of Texas System |
Prion isomers, methods of making, methods of using, and compositions and products comprising prion isomers
|
US20020160394A1
(en)
|
2001-01-24 |
2002-10-31 |
Bayer Corporation |
Regulation of transthyretin to treat obesity
|
DE60121729T2
(de)
|
2001-04-19 |
2007-11-29 |
Dr. Hermann Schätzl |
Prion Proteindimere für Impfungen
|
EP1385545B1
(en)
*
|
2001-04-30 |
2009-01-07 |
Eli Lilly And Company |
Humanized antibodies recognizing the beta-amyloid peptide
|
WO2002088307A2
(en)
|
2001-04-30 |
2002-11-07 |
Eli Lilly And Company |
Humanized antibodies
|
US6906169B2
(en)
*
|
2001-05-25 |
2005-06-14 |
United Biomedical, Inc. |
Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
|
GB0113179D0
(en)
|
2001-05-31 |
2001-07-25 |
Novartis Ag |
Organic compounds
|
AU2002345843A1
(en)
|
2001-06-22 |
2003-01-08 |
Panacea Pharmaceuticals, Inc. |
Compositions and methods for preventing protein aggregation in neurodegenerative diseases
|
JP4317010B2
(ja)
|
2001-07-25 |
2009-08-19 |
ピーディーエル バイオファーマ,インコーポレイティド |
IgG抗体の安定な凍結乾燥医薬製剤
|
US20030135035A1
(en)
|
2001-08-09 |
2003-07-17 |
Mark Shannon |
Human ZZAP1 protein
|
US20040192898A1
(en)
|
2001-08-17 |
2004-09-30 |
Jia Audrey Yunhua |
Anti-abeta antibodies
|
CA2452104A1
(en)
|
2001-08-17 |
2003-02-27 |
Eli Lilly And Company |
Use of antibodies having high affinity for soluble ass to treat conditions and diseases related to ass
|
EP1519740A4
(en)
|
2001-08-17 |
2005-11-09 |
Lilly Co Eli |
FASTER IMPROVEMENT OF COGNITION IN DISEASES ASSOCIATED WITH A-BETA
|
US20030082191A1
(en)
|
2001-08-29 |
2003-05-01 |
Poduslo Joseph F. |
Treatment for central nervous system disorders
|
EP1435774B1
(en)
|
2001-09-10 |
2010-08-25 |
AntiCancer, Inc. |
Enhanced resolution of tumor metastasis
|
US6907297B2
(en)
|
2001-09-28 |
2005-06-14 |
Ethicon, Inc. |
Expandable intracardiac return electrode and method of use
|
US7781413B2
(en)
|
2001-10-31 |
2010-08-24 |
Board Of Regents, The University Of Texas System |
SEMA3B inhibits tumor growth and induces apoptosis in cancer cells
|
WO2003039485A2
(en)
|
2001-11-08 |
2003-05-15 |
Protein Design Labs |
Stable liquid pharmaceutical formulation of igg antibodies
|
CA2466841A1
(en)
|
2001-11-21 |
2003-06-05 |
New York University |
Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid .beta., prion protein, amylin, .alpha.-synuclein, or polyglutamine repeats for induction of an immune response thereto
|
WO2003051374A2
(en)
|
2001-12-17 |
2003-06-26 |
New York State Office Of Mental Health |
SEQUESTRATION OF Aβ IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
|
AR038568A1
(es)
|
2002-02-20 |
2005-01-19 |
Hoffmann La Roche |
Anticuerpos anti-a beta y su uso
|
EP1476120B1
(en)
|
2002-02-21 |
2010-09-29 |
Duke University |
Treatment methods using anti-cd22 antibodies
|
MY139983A
(en)
*
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
US7132100B2
(en)
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
SI1524994T1
(sl)
|
2002-07-19 |
2011-08-31 |
Cytos Biotechnology Ag |
Sestavki cepiv, ki vsebujejo amiloidne beta 1-6 antigenske mreĹľe
|
WO2004013172A2
(en)
|
2002-07-24 |
2004-02-12 |
Innogenetics N.V. |
Fragments of beta-amyloid as targets for vaccination against alzheimer disease
|
JP2006508072A
(ja)
|
2002-10-01 |
2006-03-09 |
ノースウエスタン ユニバーシティ |
アミロイドベータ由来拡散性リガンド(ADDLs)、ADDL代替物、ADDL結合性分子、およびそれらの使用
|
FR2846667B1
(fr)
|
2002-11-06 |
2004-12-31 |
Pasteur Institut |
Fragments variables d'anticorps de camelides a chaine unique diriges contre le peptide beta-amyloide 1-42 et leurs applications pour le diagnostic et le traitement des maladies neuroagregatives
|
WO2004055164A2
(en)
|
2002-12-13 |
2004-07-01 |
Abgenix, Inc. |
System and method for stabilizing antibodies with histidine
|
US6787129B1
(en)
|
2003-01-13 |
2004-09-07 |
Zenitech Llc |
Castor polyester as gloss agents in anionic systems
|
CN1745175A
(zh)
|
2003-02-01 |
2006-03-08 |
神经实验室有限公司 |
自动免疫产生针对可溶性A-β的抗体
|
ES2344645T3
(es)
|
2003-02-10 |
2010-09-02 |
Applied Molecular Evolution, Inc. |
Moleculas de union al abeta.
|
AU2004229335C1
(en)
|
2003-04-04 |
2010-06-17 |
Genentech, Inc. |
High concentration antibody and protein formulations
|
EP1480041A1
(en)
|
2003-05-22 |
2004-11-24 |
Innogenetics N.V. |
Method for the prediction, diagnosis and differential diagnosis of Alzheimer's disease
|
TWI306458B
(en)
*
|
2003-05-30 |
2009-02-21 |
Elan Pharma Int Ltd |
Humanized antibodies that recognize beta amyloid peptide
|
WO2005002444A1
(en)
|
2003-07-07 |
2005-01-13 |
Agency For Science, Technology And Research |
Method and apparatus for extracting third ventricle information
|
WO2005014041A2
(en)
|
2003-07-24 |
2005-02-17 |
Novartis Ag |
Use of an amyloid beta dna vaccine for the treatment and/or prevention of amyloid diseases
|
US20060233788A1
(en)
|
2003-09-05 |
2006-10-19 |
Heiman Mark L |
Anti-ghrelin antibodies
|
CA2445743A1
(en)
|
2003-10-08 |
2005-04-08 |
The University Of British Columbia |
Methods for modulating neuronal responses
|
AU2003271174A1
(en)
|
2003-10-10 |
2005-04-27 |
Chugai Seiyaku Kabushiki Kaisha |
Double specific antibodies substituting for functional protein
|
PT2336147E
(pt)
|
2003-12-17 |
2014-07-16 |
Janssen Alzheimer Immunotherap |
Conjugados transportadores de péptidos beta imunogénicos e seus processos de produção
|
SG182163A1
(en)
|
2003-12-17 |
2012-07-30 |
Wyeth Corp |
Immunogenic peptide carrier conjugates and methods of producing same
|
US20050214222A1
(en)
|
2004-02-13 |
2005-09-29 |
Mckinnon Stuart J |
In vivo imaging of amyloid plaques in glaucoma using intravenous injectable dyes
|
DK2653465T3
(da)
|
2004-03-15 |
2016-08-22 |
Janssen Pharmaceutica Nv |
Opioid-receptormodulatorer
|
AU2005270026A1
(en)
|
2004-07-02 |
2006-02-09 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Use of thioflavin radiolabeled derivatives in amyloid imaging for assessing anti-amyloid therapies
|
US7807165B2
(en)
*
|
2004-07-30 |
2010-10-05 |
Rinat Neuroscience Corp. |
Antibodies directed against amyloid-beta peptide and methods using same
|
CN101035564A
(zh)
|
2004-09-10 |
2007-09-12 |
惠氏公司 |
人源化的抗5t4抗体和抗5t4抗体/加利车霉素缀合物
|
ZA200703561B
(en)
|
2004-10-05 |
2009-09-30 |
Wyeth Corp |
Methods and compositions for improving recombinant protein production
|
US20060160161A1
(en)
|
2004-10-26 |
2006-07-20 |
Elan Pharmaceuticals, Inc. |
Methods for assessing antibodies to neurodegenerative disease-associated antigens
|
AR052051A1
(es)
|
2004-12-15 |
2007-02-28 |
Neuralab Ltd |
Anticuerpos ab humanizados usados en mejorar la cognicion
|
TW200635608A
(en)
|
2004-12-15 |
2006-10-16 |
Neuralab Ltd |
Aβ antibodies for use in improving cognition
|
WO2006066118A2
(en)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Contextual fear test for predicting efficacy of alzheimer immunotherapeutic treatment
|
WO2006066233A1
(en)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
An immunoprecipitation-based assay for predicting in vivo efficacy of beta-amyloid antibodies
|
US7625560B2
(en)
|
2004-12-15 |
2009-12-01 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
JP2008528638A
(ja)
|
2005-01-28 |
2008-07-31 |
ワイス |
ポリペプチドの安定化液体処方
|
GT200600031A
(es)
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
CA2607868A1
(en)
|
2005-05-05 |
2006-11-16 |
Merck & Co., Inc. |
Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease
|
ES2402650T3
(es)
*
|
2005-06-17 |
2013-05-07 |
Janssen Alzheimer Immunotherapy |
Métodos de purificación de anticuerpos anti A beta
|
WO2007011833A2
(en)
*
|
2005-07-18 |
2007-01-25 |
Merck & Co., Inc. |
Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
|
WO2007040201A1
(ja)
|
2005-10-04 |
2007-04-12 |
Sharp Kabushiki Kaisha |
移動局装置、基地局装置、移動局装置の使用周波数帯域マッピング方法、位置管理装置、移動局装置の位置登録方法、ページング方法、及びこれらを実行するプログラム及び記録媒体
|
EP1951750A4
(en)
|
2005-11-10 |
2009-12-09 |
Roskamp Res Llc |
MODULATION OF THE ANGIOGENESIS BY A-BETA PEPTIDE FRAGMENTS
|
EA015654B9
(ru)
|
2006-03-30 |
2012-01-30 |
Глаксо Груп Лимитед |
Антитела против бета-амилоидного пептида
|
WO2009017467A1
(en)
|
2007-07-27 |
2009-02-05 |
Elan Pharma International Limited |
Treatment of amyloidogenic diseases
|
WO2010044803A1
(en)
|
2008-10-17 |
2010-04-22 |
Elan Pharma International Limited |
Treatment of amyloidogenic diseases
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
WO2008011348A2
(en)
|
2006-07-14 |
2008-01-24 |
Ac Immune S.A. |
Humanized antibody against amyloid beta
|
JP2010521651A
(ja)
|
2007-03-12 |
2010-06-24 |
独立行政法人放射線医学総合研究所 |
脳内のアミロイド関連神経炎症の画像化
|
US8003097B2
(en)
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
JP2011526240A
(ja)
|
2007-04-18 |
2011-10-06 |
ヤンセン アルツハイマー イミュノセラピー |
脳アミロイド血管症の予防および治療
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
WO2011133919A1
(en)
|
2010-04-22 |
2011-10-27 |
Janssen Alzheimer Immunotherapy |
Use of tau to monitor immunotherapy
|
PT2237803E
(pt)
|
2007-12-28 |
2015-10-16 |
Prothena Biosciences Ltd |
Tratamento e profilaxia da amiloidose
|
TR201816335T4
(tr)
|
2008-09-18 |
2018-11-21 |
Cedars Sinai Medical Center |
Alzheimer hastalığının tespitine yönelik optik yöntem.
|
US20130084245A1
(en)
|
2010-02-25 |
2013-04-04 |
Wyeth Llc |
Pet monitoring of a-beta-directed immunotherapy
|